A distinct four-value blood signature of pyrexia under combination therapy of malignant melanoma with dabrafenib and trametinib evidenced by an algorithm-defined pyrexia score.

Autor: Hannah Schaefer, Albert Rübben, André Esser, Arturo Araujo, Oana-Diana Persa, Marike Leijs

Publikováno v: PLoS ONE, Vol 17, Iss 8, p e0273478 (2022)

Pyrexia is a frequent adverse event of BRAF/MEK-inhibitor combination therapy in patients with metastasized malignant melanoma (MM). The study's objective was to identify laboratory changes which might correlate with the appearance of pyrexia. Initia

Externí odkaz: https://doaj.org/article/4bb78c2180484fc3bbdb5ab5a4882896

Cutaneous malignancies in tattoos, a case series of six patients

Autor: Sebastiaan A. S. van der Bent, Marike M. Leijs, Albert Rübben, Thomas Rustemeyer, Claudio Cacchi, Hannah Schaefer

Publikováno v: Leijs, M, Schaefer, H, Rübben, A, Cacchi, C, Rustemeyer, T & van der Bent, S 2021, ' Cutaneous malignancies in tattoos, a case series of six patients ', Current Oncology, vol. 28, no. 6, pp. 4721-4737 . https://doi.org/10.3390/curroncol28060398
Current Oncology, 28(6), 4721-4737. Multidisciplinary Digital Publishing Institute (MDPI)
Current Oncology, Vol 28, Iss 398, Pp 4721-4737 (2021)
Current Oncology
Volume 28
Issue 6
Pages 398-4737

Background: A variety of side effects following the tattooing of the skin were reported over the years. Analytical studies showed that some tattoo inks contain harmful compounds. Methods: We presented six patient cases with cutaneous malignancies in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e9f939b14173f45e29c126a457b2280
https://research.vumc.nl/en/publications/a343e184-cfea-44dd-8bda-b437d186ea59